Efficacy and safety of bevacizumab in the treatment of adult gliomas: a systematic review and meta-analysis

OBJECTIVE: To assess the efficacy and safety of bevacizumab (BEV) in patients with glioma. DESIGN: Systematic review and meta-analysis. PARTICIPANTS: Adults aged 18 years and above, whose histology was confirmed to be malignant glioma. PRIMARY AND SECONDARY OUTCOME MEASURES: The main indicators incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huan, Guo, Jianxin, Wang, Tianze, Wang, Kai, Wu, Zhuojun, Sun, Tianze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640637/
https://www.ncbi.nlm.nih.gov/pubmed/34857558
http://dx.doi.org/10.1136/bmjopen-2021-048975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640637/
https://www.ncbi.nlm.nih.gov/pubmed/34857558
http://dx.doi.org/10.1136/bmjopen-2021-048975

Ejemplares similares